AHR Price Prediction Next Week
Analysis and Insights
News Sentiment and Analyst Ratings:
Recent news indicates strong analyst support for American Healthcare REIT (AHR). Citizens JMP raised the price target from $30 to $35, maintaining an Outperform rating, citing strong growth in senior housing segments despite a Q4 core FFO miss. RBC Capital also maintains a Buy rating with a $34 target. The stock has a Strong Buy consensus among analysts, with a 19.34% potential upside.
Technical Analysis:
The stock is trading at $30.42, with a Fibonacci pivot at $29.12. Key resistance levels are at $30.85 (R1) and $31.93 (R2), while support is at $28.04 (S1) and $26.31 (S3). The RSI is at 53.35, indicating a neutral position, while the MACD shows a bullish signal with a positive crossover.
Price Forecast:
Based on the positive news sentiment, analyst upgrades, and technical indicators, AHR is expected to rise next week. The target price is $31.50.
Recommendation:
Buy AHR at the current price of $30.42, targeting $31.50, with a stop-loss at $28.00.
AHR Similar Chart Price Prediction
The price of AHR is predicted to go up -3.66%, based on the high correlation periods with CW. The similarity of these two price pattern on the periods is 93.08%.
AHR
CW
Down: -3.66%Similarity: 93.08%
AHR Revenue Forecast
AHR EPS Forecast
AHR FAQs
What is AHR revenue forecast for next quarter？
AHR Analyst's Forecast
Aaron Hecht
Citizens Capital Markets
Buy
2025-03-04
Price Target
$30 → $35
Upside
+14.08%
Citizens JMP raised the firm's price target on American Healthcare REIT to $35 from $30 and keeps an Outperform rating on the shares. American Healthcare's Q4 core FFO miss vs. the firm's estimate was primarily related to dispositions and ATM activity, while the integrated senior health campuses and senior housing operating property segments saw "exceptional" growth during the quarter, the analyst tells investors in a research note. American Healthcare REIT is uniquely positioned to outperform over the foreseeable future given its exposure to senior housing REIT Investment Diversification and Empowerment Act assets, which carries some of the best fundamentals in real estate, the firm says.
Ronald Kamdem
Morgan Stanley
Buy
2024-12-30
Price Target
$27 → $29
Upside
+2.96%
Michael Carroll
RBC Capital
Buy
2024-11-18
Price Target
$28 → $30
Upside
+9.57%
